An association study between hypoxia inducible factor-1alpha (HIF-1α) polymorphisms and osteonecrosis

Area of Science:

• Molecular Biology
• Genetics
• Orthopedics

Background:

• Osteonecrosis (ON) is a bone disease often resulting from hypoxia due to impaired blood flow.
• Hypoxia-Inducible Factor 1-alpha (HIF-1α) is a key transcription factor activated by low oxygen conditions.
• Understanding the genetic factors influencing ON susceptibility is crucial for early diagnosis and treatment.

Purpose of the Study:

• To investigate the potential genetic association between HIF-1α gene polymorphisms and susceptibility to osteonecrosis (ON).
• To evaluate the functional impact of identified HIF-1α mutations on protein activity, expression, and localization.

Main Methods:

• Analysis of three known HIF-1α polymorphisms (C111A, C1772T, G1790A) in a Greek population cohort.
• Genotyping performed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) and sequencing.
• In vitro assessment of mutant HIF-1α protein function (activity, expression, localization) in HEK293 and Saos-2 cell lines.

Main Results:

• No significant differences in genotype or allele frequencies of HIF-1α SNPs (C1772T and G1790A) were observed between ON patients and controls.
• These HIF-1α SNPs were not associated with different subgroups of osteonecrosis.
• Mutations corresponding to these SNPs (P582S and A588T) did not significantly alter HIF-1α protein activity, expression, or localization in cellular assays.

Conclusions:

• The studied missense mutations in the HIF-1α gene are unlikely to be significant risk factors for developing osteonecrosis.
• Genetic variations in HIF-1α analyzed in this study do not appear to play a major role in osteonecrosis pathogenesis.
• Further research may be needed to explore other genetic or environmental factors contributing to ON development.